Long-term use of metformin and the molecular subtype in invasive breast carcinoma patients – a retrospective study of clinical and tumor characteristics

BACKGROUND: Metformin may exhibit inhibitory effects on cancer cells by inhibiting mTOR signaling pathway. The aim of our retrospective study was to examine if patients with breast carcinoma (BC) and diabetes mellitus (DM) receiving metformin have a lower stage of carcinoma in comparison to patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Besic, Nikola, Satej, Nika, Ratosa, Ivica, Horvat, Andreja Gojkovic, Marinko, Tanja, Gazic, Barbara, Petric, Rok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005811/
https://www.ncbi.nlm.nih.gov/pubmed/24774412
http://dx.doi.org/10.1186/1471-2407-14-298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005811/
https://www.ncbi.nlm.nih.gov/pubmed/24774412
http://dx.doi.org/10.1186/1471-2407-14-298

Ejemplares similares